NSEShareholders meeting2d ago · 10 Aug 2026, 11:35 pm

Shareholders meeting

AstraZeneca Pharma India Limited · ASTRAZEN

✦ AI SummaryResults

AstraZeneca Pharma India Limited has held its 47th Annual General Meeting (AGM) on August 10, 2026, where it adopted financial statements, declared a dividend of Rs. 36 per equity share, and appointed new auditors and directors. The meeting was conducted through video conferencing, and remote e-voting was provided to members.

Analysis Scores

Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact9/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

AstraZeneca Pharma India Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 10, 2026

Attachments (1)

📄

ASTRAZEN_10082026233540_Proceedings_of_AGM_2026.pdf

pdf

Download →
View document text
August 10, 2026 The Manager- Listing BSE Limited P J Towers, Dalal Street, Fort, Mumbai - 400001 National Stock Exchange of India Limited Exchange Plaza, Bandra –Kurla Complex, Bandra (E), Mumbai - 400051 Dear Sir/ Madam, Sub: Summary of Proceedings of 47th Annual General Meeting Ref: Scrip code –BSE: 506820, NSE: ASTRAZEN Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the 47th Annual General Meeting ("AGM") of the Company was held on Monday, August 10, 2026 through Video Conferencing ("VC")/Other Audio Visual Means ("OAVM"). As the requisite quorum was not present at the scheduled time of 3:00 P.M., the AGM commenced at 3:18 P.M. and concluded at 5:20 P.M. The following business items were transacted at the AGM: 1. Adoption of Financial Statements for the financial year ended March 31, 2026 and the Reports of the Board of Directors and Auditors thereon. 2. Declaration of dividend of Rs. 36/- per equity share. 3. Appointment of Ms. Bhavana Agrawal (DIN: 10485441) who retires by rotation, and being eligible, offers herself for re-appointment. 4. Appointment of M/s. BSR & Co. LLP, Chartered Accountants (Firm Registration No. 101248W/W- 00022) as the Statutory Auditors of the Company. 5. Re-appointment of Ms. Shilpa Divekar Nirula as an Independent Director for a second term of five (5) years consecutive years commencing from December 29, 2026 to December 28, 2031 (both days inclusive). The Company had provided remote e-Voting facility to the members to exercise their votes electronically from Thursday, August 6, 2026 at 9:00 a.m. (IST) and ended on Sunday, August 9, 2026 at 5:00 p.m. (IST) on the resolutions as set out at Item Nos. 1 to 5 of the Notice of the AGM. Members who participated at the 47th AGM through VC/ OAVM facility and had not cast their votes on the resolution(s) using remote e Voting, and who were otherwise eligible, were provided facility to e-Vote on the NSDL portal during the AGM. Kindly note that voting results will be announced upon the receipt of Scrutinizer’s Report and will be submitted as per Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Please take same on record. Thanking you, For AstraZeneca Pharma India Limited Tanya Sanish Company Secretary & Compliance Officer